Latest Strategic Expansion News

5G Networks Limited (5GN) reported a robust 27% revenue increase in FY25, driven by organic growth and a strategic acquisition of an 89.65% stake in cybersecurity firm AUCyber. The company’s underlying EBITDA turned positive, signaling a financial turnaround despite integration costs.

5G Networks has reported a strong FY25 with an 8% revenue increase and a positive EBITDA turnaround, driven by the strategic acquisition of cyber security firm AUCyber. The company’s expansion into sovereign cloud services signals a new growth chapter.

Jcurve Solutions Limited reported a significant turnaround in FY25 with a Normalised EBITDA profit and a narrowed net loss, despite an 11% revenue decline. The company also strengthened its Asia presence through acquisition and boosted liquidity with a $1 million capital raise.

BPH Global Limited reported a strong 161.7% revenue increase to nearly $288,000 for FY25, driven by new seaweed operations in Indonesia, yet the company remains in the red with a $1.3 million net loss. The firm continues to raise capital and integrate acquisitions as it charts a path forward.

Elixinol Wellness Limited reported a 12.8% increase in revenue to $7.64 million for the half-year ended June 2025, yet its net loss widened by 12.2% to $3.09 million, reflecting higher marketing and restructuring expenses following recent acquisitions.

Rhythm Biosciences has significantly reduced its annual loss by 44%, boosted by a 91% rise in other income, while launching a new wholly owned subsidiary, RHY GeneType Pty Ltd.

Victor Group Holdings has sharply reduced its FY25 loss to $275,449 from $3.53 million the prior year, while expanding its fintech presence through strategic stakes in LIT Technology and iRich Finance.

Radiopharm Theranostics reported a dramatic revenue surge to $3.63 million alongside a 20% reduction in net loss for FY2025, while increasing its stake in Radiopharm Ventures to 75%.

SenSen Networks has reported a strong financial turnaround in FY2025, driven by rapid expansion in North America and innovative AI kerb enforcement technology. The company’s improved margins and positive cash flow signal a promising outlook for its Smart Cities strategy.

HighCom Limited reports a sharp 90% reduction in net loss for FY25, turning EBITDA positive and advancing new product development with XTclave technology. Leadership changes and strategic focus set the stage for growth despite cautious US market conditions.

BCAL Diagnostics has launched its first commercial breast cancer diagnostic test, BREASTESTplus™, in Australia, marking a key milestone despite a $7.24 million loss for FY2025. The company is also advancing its US operations with a new subsidiary and clinical trials underway.

EPX Limited reported a robust 17% increase in revenue for FY2025, driven by a surge in recurring revenue and strategic expansion into industrial sectors following the Coda Cloud acquisition.